Table 3.
Latest follow-up of late steroid-resistant nephrotic syndrome
| Patient characteristics | CR | PR | NR | ESRD |
|---|---|---|---|---|
| N (% of total patients) | 14 (48) | 6 (21) | 6 (21) | 3 (10) |
| Ethnicity (C:AA:O) | 7:5:2 | 3:2:1 | 1:3:2 | 1:2:0 |
| Sex (M:F) | 8:6 | 3:3 | 6:0 | 2:1 |
| Age (years) | 9.8±3.9 | 14.2±3.9 | 10.3±3.0 | 15.1±4.6 |
| Median time to LSR (months)а | 11.5 (2–84) | 21 (6–152) | 38.5 (6–112) | 58 (18–170) |
| Duration of follow-up (months) | 64.5 (24–160) | 72 (49–184) | 89 (48–126) | 134 (90–227) |
| eGFR (ml/min/1.73 m2) | 128.4±25.3 | 126.9±32.7 | 98.8±19.1 | N/A |
| Serum albumin (g/dL) | 4.2±0.4 | 3.7±0.6 | 1.6±0.6 | 3.0±2.0 (n=2) |
| Up/c (mg/mg) | 0.09±0.07 | 1.1±0.9 | 6.5±4.1 | N/A |
C:AA:O, Caucasian:African American:Other; LSR, late steroid resistance; ESRD, end-stage renal disease; N/A, not available or n<2
Data are presented as the mean ± SD or as the median with the range in parenthesis
а
p=0.07 median time to LSR vs. final outcome